Select Page
Upload
Change your cover photo
Upload
Apply Cancel
Change your cover photo
PR Newswire
PR Newswire
This user account status is Approved

Posts:

Chenghe Acquisition II Co. Announces the Separate Trading of Its Class A Ordinary Shares and Warrants, Commencing on July 29, 2024

SINGAPORE, July 27, 2024 /PRNewswire/ — Chenghe Acquisition II Co. (the “Company”) today announced that, commencing on July 29, 2024, holders of the units (the “Units”) sold in the Company’s initial public offering may elect to separately trade the Company’s Class A Ordinary Shares (the “Shares”) and warrants (the “Warrants”) included in the Units. The Shares and Warrants received from the separated Units will trade on the NYSE...

Read More
vivo Unveils Future Imaging Trends and Announces Winners of VISION+ Mobile PhotoAwards 2024

XINING, China, July 27, 2024 /PRNewswire/ — vivo today held the 2024 vivo Imaging Conference in Xining, China, where it showcased vivo’s latest advancements in imaging technologies. The company presented its progressive strategies surrounding three new trends in mobile imaging: imaging security, 3D imaging/XR and health imaging. In addition, the results of the VISION+ Mobile PhotoAwards 2024 were also revealed, with photographer He Jinyi’s captivating work, “A Fleeting...

Read More
WiMi Built an Advanced Data Structure Architecture Using Homomorphic Encryption and Federated Learning

BEIJING, July 26, 2024 /PRNewswire/ — WiMi Hologram Cloud Inc. (NASDAQ: WIMI) (“WiMi” or the “Company”), a leading global Hologram Augmented Reality (“AR”) Technology provider, today announced that it utilized homomorphic encryption and federated learning building an advanced data structure architecture. The architecture integrates federated learning and partial homomorphic encryption, and this integration protects data privacy while enabling efficient...

Read More
CStone Announces European Commission Approval of Sugemalimab (Cejemly®) as First-Line Treatment for Non-Small Cell Lung Cancer

Sugemalimab becomes the world’s first anti-PD-L1 monoclonal antibody (mAb) approved in Europe for first-line treatment of both squamous and non-squamous non-small cell lung cancer (NSCLC), also marking the first successful international approval of a China domestic anti-PD-L1 mAb. The European Commission (EC) approval is based on the results of GEMSTONE-302 Phase 3 trial, which demonstrated that sugemalimab in combination with chemotherapy significantly prolonged progression-free...

Read More
2024 CICC GBA Wealth Management Forum successfully held in Hong Kong

BEIJING, July 26, 2024 /PRNewswire/ — On 25th July, China International Capital Corporation Limited (CICC) successfully held the 2024 CICC GBA Wealth Management Forum in Hong Kong. Themed “Developing New Quality Productive Forces, Driving New Momentum in Wealth”, the forum gathered a multitude of distinguished representatives from various sectors within the Guangdong-Hong Kong-Macao Greater Bay Area (the Greater Bay Area). They engaged in in-depth and comprehensive...

Read More
STONE Accounting Group Announces Strategic Rebranding and Business Expansion

STONE Accounting Group is undergoing a rebranding process to redefine the accounting experience, making excellence not just a standard but a catalyst for success in the dynamic, interconnected world. Rooted in principles of innovation and integrity, this initiative unveils a modern identity emphasizing fostering strategic partnerships, empowering clients globally, and expanding their international presence to deliver personalized, top-tier accounting and advisory services. MELBOURNE,...

Read More